GeoVax Historical Financial Ratios

GOVX Stock

USD 2.64 0.07 2.58%

GeoVax Labs is recently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.27 or Days Sales Outstanding of 50.76 will help investors to properly organize and evaluate GeoVax Labs financial condition quickly.

Quick Ratio Current Ratio

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

About GeoVax Financial Ratios Analysis

GeoVax LabsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate GeoVax Labs investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on GeoVax financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across GeoVax Labs history.

GeoVax Labs Financial Ratios Chart

At this time, GeoVax Labs' Book Value Per Share is fairly stable compared to the past year. Average Payables is likely to rise to about 413.4 K in 2024, whereas Price To Sales Ratio is likely to drop 323.73 in 2024.

Days Sales Outstanding Book Value Per Share Average Payables Stock Based Compensation To Revenue

Add Fundamental

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Stock Based Compensation To Revenue

A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.

Most ratios from GeoVax Labs' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into GeoVax Labs current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.At this time, GeoVax Labs' Book Value Per Share is fairly stable compared to the past year. Average Payables is likely to rise to about 413.4 K in 2024, whereas Price To Sales Ratio is likely to drop 323.73 in 2024.

	2021	2023	2024 (projected)
Graham Number	16.79	22.85	23.99
Receivables Turnover	7.86	9.03	16.17

Graham Number Receivables Turnover

GeoVax Labs fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.04	-0.23	-0.13	0.23	0.28	0.93	0.0	0.04	1.0	0.27	0.56	0.3	0.85	0.97	-0.25	0.98	0.01	-0.27	-0.13	0.29	0.0	-0.12	-0.11	0.07	0.6
Ptb Ratio	0.04		-0.11	-0.07	0.11	0.12	-0.04	0.72	1.0	0.04	-0.2	-0.72	0.13	0.07	0.0	0.19	0.06	0.71	-0.11	-0.2	0.13	-0.72	-0.09	-0.06	-0.16	-0.7
Days Sales Outstanding	-0.23	-0.11		0.19	-0.31	-0.38	-0.33	-0.28	-0.11	-0.23	-0.23	-0.17	-0.35	-0.45	-0.33	-0.17	-0.35	-0.27	0.23	0.38	-0.35	0.29	0.33	0.11	0.41	-0.19
Book Value Per Share	-0.13	-0.07	0.19		-0.4	-0.57	0.01	-0.14	-0.07	-0.13	-0.49	-0.03	-0.57	-0.28	-0.03	-0.61	-0.08	-0.06	0.96	0.29	-0.57	0.15	0.27	0.9	0.6	-0.02
Free Cash Flow Yield	0.23	0.11	-0.31	-0.4		0.95	0.01	0.13	0.11	0.23	0.85	0.25	0.83	0.64	0.13	0.42	0.19	0.04	-0.39	-0.31	0.83	-0.13	-0.29	-0.22	-0.19	0.23
Operating Cash Flow Per Share	0.28	0.12	-0.38	-0.57	0.95		0.06	0.15	0.12	0.28	0.9	0.28	0.96	0.71	0.17	0.52	0.24	0.05	-0.61	-0.42	0.96	-0.15	-0.39	-0.39	-0.3	0.27
Average Payables	0.93	-0.04	-0.33	0.01	0.01	0.06		-0.06	-0.04	0.93	0.08	0.57	0.08	0.72	0.98	-0.46	0.97	-0.02	-0.11	-0.02	0.07	0.05	-0.02	-0.04	0.06	0.61
Capex To Depreciation	0.0	0.72	-0.28	-0.14	0.13	0.15	-0.06		0.72	0.0	-0.3	-0.63	0.16	0.03	-0.07	0.34	-0.04	0.99	-0.16	0.0	0.16	-1.0	0.15	-0.07	-0.17	-0.61
Pb Ratio	0.04	1.0	-0.11	-0.07	0.11	0.12	-0.04	0.72		0.04	-0.2	-0.72	0.13	0.07	0.0	0.19	0.06	0.71	-0.11	-0.2	0.13	-0.72	-0.09	-0.06	-0.16	-0.7
Ev To Sales	1.0	0.04	-0.23	-0.13	0.23	0.28	0.93	0.0	0.04		0.27	0.56	0.31	0.85	0.97	-0.25	0.98	0.01	-0.27	-0.13	0.29	0.0	-0.12	-0.11	0.07	0.6
Free Cash Flow Per Share	0.27	-0.2	-0.23	-0.49	0.85	0.9	0.08	-0.3	-0.2	0.27		0.55	0.85	0.67	0.19	0.35	0.25	-0.4	-0.52	-0.4	0.85	0.3	-0.44	-0.35	-0.21	0.53
Roic	0.56	-0.72	-0.17	-0.03	0.25	0.28	0.57	-0.63	-0.72	0.56	0.55		0.29	0.61	0.58	-0.28	0.56	-0.63	-0.11	-0.04	0.29	0.63	-0.13	0.04	0.15	1.0
Inventory Turnover	0.3	0.13	-0.35	-0.57	0.83	0.96	0.08	0.16	0.13	0.31	0.85	0.29		0.72	0.18	0.55	0.25	0.07	-0.67	-0.39	1.0	-0.16	-0.37	-0.41	-0.21	0.28
Net Income Per Share	0.85	0.07	-0.45	-0.28	0.64	0.71	0.72	0.03	0.07	0.85	0.67	0.61	0.72		0.8	0.02	0.84	0.0	-0.43	-0.31	0.71	-0.04	-0.3	-0.16	-0.04	0.63
Days Of Inventory On Hand	0.97	0.0	-0.33	-0.03	0.13	0.17	0.98	-0.07	0.0	0.97	0.19	0.58	0.18	0.8		-0.4	1.0	-0.05	-0.16	-0.12	0.17	0.07	-0.12	-0.05	0.05	0.63
Payables Turnover	-0.25	0.19	-0.17	-0.61	0.42	0.52	-0.46	0.34	0.19	-0.25	0.35	-0.28	0.55	0.02	-0.4		-0.33	0.27	-0.61	-0.25	0.54	-0.34	-0.21	-0.45	-0.3	-0.3
Average Inventory	0.98	0.06	-0.35	-0.08	0.19	0.24	0.97	-0.04	0.06	0.98	0.25	0.56	0.25	0.84	1.0	-0.33		-0.02	-0.21	-0.16	0.24	0.03	-0.16	-0.08	0.04	0.61
Capex To Revenue	0.01	0.71	-0.27	-0.06	0.04	0.05	-0.02	0.99	0.71	0.01	-0.4	-0.63	0.07	0.0	-0.05	0.27	-0.02		-0.08	0.03	0.07	-0.99	0.18	0.0	-0.12	-0.61
Cash Per Share	-0.27	-0.11	0.23	0.96	-0.39	-0.61	-0.11	-0.16	-0.11	-0.27	-0.52	-0.11	-0.67	-0.43	-0.16	-0.61	-0.21	-0.08		0.34	-0.66	0.16	0.32	0.86	0.51	-0.11
Pocfratio	-0.13	-0.2	0.38	0.29	-0.31	-0.42	-0.02	0.0	-0.2	-0.13	-0.4	-0.04	-0.39	-0.31	-0.12	-0.25	-0.16	0.03	0.34		-0.38	0.0	0.99	0.17	0.63	-0.04
Interest Coverage	0.29	0.13	-0.35	-0.57	0.83	0.96	0.07	0.16	0.13	0.29	0.85	0.29	1.0	0.71	0.17	0.54	0.24	0.07	-0.66	-0.38		-0.16	-0.35	-0.41	-0.21	0.28
Capex To Operating Cash Flow	0.0	-0.72	0.29	0.15	-0.13	-0.15	0.05	-1.0	-0.72	0.0	0.3	0.63	-0.16	-0.04	0.07	-0.34	0.03	-0.99	0.16	0.0	-0.16		-0.14	0.08	0.18	0.61
Pfcf Ratio	-0.12	-0.09	0.33	0.27	-0.29	-0.39	-0.02	0.15	-0.09	-0.12	-0.44	-0.13	-0.37	-0.3	-0.12	-0.21	-0.16	0.18	0.32	0.99	-0.35	-0.14		0.16	0.6	-0.13
Days Payables Outstanding	-0.11	-0.06	0.11	0.9	-0.22	-0.39	-0.04	-0.07	-0.06	-0.11	-0.35	0.04	-0.41	-0.16	-0.05	-0.45	-0.08	0.0	0.86	0.17	-0.41	0.08	0.16		0.55	0.04
Income Quality	0.07	-0.16	0.41	0.6	-0.19	-0.3	0.06	-0.17	-0.16	0.07	-0.21	0.15	-0.21	-0.04	0.05	-0.3	0.04	-0.12	0.51	0.63	-0.21	0.18	0.6	0.55		0.16
Roe	0.6	-0.7	-0.19	-0.02	0.23	0.27	0.61	-0.61	-0.7	0.6	0.53	1.0	0.28	0.63	0.63	-0.3	0.61	-0.61	-0.11	-0.04	0.28	0.61	-0.13	0.04	0.16

Click cells to compare fundamentals

GeoVax Labs Account Relationship Matchups

GeoVax Labs fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	388.79	70.64	358.22	296.32	340.77	323.73
Ptb Ratio	(290.35)	13.46	31.62	0.9	2.39	2.27
Days Sales Outstanding	46.17	21.29	36.57	46.46	53.43	50.76
Book Value Per Share	(0.62)	3.77	1.72	10.47	2.27	2.38
Free Cash Flow Yield	(0.003076)	(0.0226)	(0.0815)	(0.8)	(1.83)	(1.74)
Operating Cash Flow Per Share	(0.55)	(1.08)	(4.41)	(7.49)	(9.91)	(9.42)
Stock Based Compensation To Revenue	0.28	0.0354	0.96	11.14	10.02	10.52
Pb Ratio	(290.35)	13.46	31.62	0.9	2.39	2.27
Ev To Sales	388.58	65.32	328.55	(44.58)	(51.27)	(48.71)
Free Cash Flow Per Share	(0.55)	(1.14)	(4.43)	(7.55)	(9.93)	(9.43)
Roic	1.55	(0.29)	(4.29)	(0.53)	(4.64)	(4.41)
Net Income Per Share	(0.94)	(1.16)	(7.3)	(5.52)	(10.22)	(9.71)
Payables Turnover	12.52	9.13	7.56	0.0322	7.39	9.7
Sales General And Administrative To Revenue	1.39	1.2	9.29	61.57	70.8	47.83
Research And Ddevelopement To Revenue	1.62	1.34	40.4	112.63	101.37	106.44
Cash Per Share	0.11	3.89	4.5	10.87	2.54	2.67
Pocfratio	(326.91)	(46.82)	(12.32)	(1.26)	(0.55)	(0.57)
Pfcf Ratio	(325.14)	(44.29)	(12.27)	(1.25)	(0.55)	(0.57)
Days Payables Outstanding	29.16	39.97	48.28	11.3K	49.37	46.91
Roe	1.51	(0.31)	(4.25)	(0.53)	(4.51)	(4.28)
Ev To Operating Cash Flow	(326.73)	(43.29)	(11.3)	0.19	(0.29)	(0.31)
Pe Ratio	(192.49)	(43.82)	(7.44)	(1.71)	(0.53)	(0.56)
Return On Tangible Assets	(5.07)	(0.28)	(1.57)	(0.45)	(2.8)	(2.94)
Ev To Free Cash Flow	(324.97)	(40.96)	(11.25)	0.19	(0.29)	(0.3)
Earnings Yield	(0.005195)	(0.0228)	(0.13)	(0.58)	(1.89)	(1.79)
Net Debt To E B I T D A	0.1	3.47	0.62	1.98	0.24	0.26
Current Ratio	0.22	12.63	2.14	6.1	2.24	2.13
Tangible Book Value Per Share	(0.62)	3.77	1.72	10.47	2.27	2.38
Receivables Turnover	17.99	7.91	17.14	7.86	9.03	16.17
Graham Number	3.61	9.9	16.79	36.06	22.85	23.99

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity	Operating Cycle
Cash Conversion Cycle

GeoVax Historical Financial Ratios

About GeoVax Financial Ratios Analysis

GeoVax Labs Financial Ratios Chart

Book Value Per Share

Average Payables

Stock Based Compensation To Revenue

GeoVax Labs fundamentals Correlations

GeoVax Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

GeoVax Labs fundamentals Accounts

Also Currently Popular

Additional Tools for GeoVax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Roe	+ 1.0	Roic
Interest Coverage	+ 1.0	Inventory Turnover
Average Inventory	+ 1.0	Days Of Inventory On Hand
Capex To Revenue	+ 0.99	Capex To Depreciation

Capex To Operating Cash Flow	- 1.0	Capex To Depreciation
Capex To Operating Cash Flow	- 0.99	Capex To Revenue
Capex To Operating Cash Flow	- 0.72	Pb Ratio
Roic	- 0.72	Pb Ratio
Capex To Operating Cash Flow	- 0.72	Ptb Ratio
Roic	- 0.72	Ptb Ratio